Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
EXEL
EXELIXIS, INC.
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$58.41
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$14.47B
RECENT INSIDER TRADES
2026-08-12
· Beckerle Mary C
(Director)
· SELL
2026-06-03
· WYSZOMIERSKI JACK L
(Director)
· SELL
2026-06-03
· Eckhardt Sue Gail
(Director)
· SELL
2026-05-29
· Smith Julie
(Director)
· OTHER
2026-05-29
· Eckhardt Sue Gail
(Director)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
813
Shares held
326,720,258
Value
$15.42B
Percent of shares outstanding
131.86%
As of quarter end
2026-06-30
RECENT NEWS
Exelixis stock hits all-time high at 59.73 USD
Exelixis presents at Morgan Stanley healthcare conference
Exelixis plans Zanza launch as CABOMETYX growth faces NET ramp hurdle
Exelixis experiences 3-month delay
Exelixis faces FDA delay with limited cost impact
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS